vs

Side-by-side financial comparison of Amber International Holding Ltd (AMBR) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

Amber International Holding Ltd is the larger business by last-quarter revenue ($1.9M vs $1.8M, roughly 1.1× INVO Fertility, Inc.). Amber International Holding Ltd runs the higher net margin — 87.5% vs -150.5%, a 238.1% gap on every dollar of revenue.

Amber Road, Inc. (NYSE: AMBR) was a US-based software company specializing in Global Trade Management (GTM) solutions. It was acquired by E2open in 2019.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

AMBR vs IVF — Head-to-Head

Bigger by revenue
AMBR
AMBR
1.1× larger
AMBR
$1.9M
$1.8M
IVF
Higher net margin
AMBR
AMBR
238.1% more per $
AMBR
87.5%
-150.5%
IVF

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
AMBR
AMBR
IVF
IVF
Revenue
$1.9M
$1.8M
Net Profit
$1.6M
$-2.6M
Gross Margin
39.9%
Operating Margin
1.5%
-93.1%
Net Margin
87.5%
-150.5%
Revenue YoY
22.6%
Net Profit YoY
-62.2%
EPS (diluted)
$0.02
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBR
AMBR
IVF
IVF
Q3 25
$1.8M
Q2 25
$1.9M
$1.9M
Q1 25
$1.6M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.8M
Q1 24
$1.6M
Q4 23
$1.4M
Net Profit
AMBR
AMBR
IVF
IVF
Q3 25
$-2.6M
Q2 25
$1.6M
$-5.3M
Q1 25
$-17.4M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.6M
Q4 23
$-2.0M
Gross Margin
AMBR
AMBR
IVF
IVF
Q3 25
Q2 25
39.9%
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
AMBR
AMBR
IVF
IVF
Q3 25
-93.1%
Q2 25
1.5%
-160.4%
Q1 25
-1042.1%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-109.2%
Net Margin
AMBR
AMBR
IVF
IVF
Q3 25
-150.5%
Q2 25
87.5%
-283.6%
Q1 25
-1060.1%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-122.2%
Q1 24
-101.3%
Q4 23
-144.4%
EPS (diluted)
AMBR
AMBR
IVF
IVF
Q3 25
$-0.77
Q2 25
$0.02
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBR
AMBR
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$25.8M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$91.3M
$5.8M
Total Assets
$248.2M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBR
AMBR
IVF
IVF
Q3 25
Q2 25
$25.8M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Total Debt
AMBR
AMBR
IVF
IVF
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
AMBR
AMBR
IVF
IVF
Q3 25
$5.8M
Q2 25
$91.3M
$2.6M
Q1 25
$3.3M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$1.4M
Q1 24
$10.2K
Q4 23
$892.8K
Total Assets
AMBR
AMBR
IVF
IVF
Q3 25
$18.8M
Q2 25
$248.2M
$19.3M
Q1 25
$31.7M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
Q1 24
$17.3M
Q4 23
$18.5M
Debt / Equity
AMBR
AMBR
IVF
IVF
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBR
AMBR
IVF
IVF
Operating Cash FlowLast quarter
$-4.1M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
-2.49×
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBR
AMBR
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-4.1M
$-1.7M
Q1 25
$-3.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-714.9K
Free Cash Flow
AMBR
AMBR
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
AMBR
AMBR
IVF
IVF
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
AMBR
AMBR
IVF
IVF
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23
Cash Conversion
AMBR
AMBR
IVF
IVF
Q3 25
Q2 25
-2.49×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons